-
Mashup Score: 0Eli Lilly’s Zepbound Becomes First FDA-Approved Drug Therapy for Sleep Apnea - MedCity News - 2 hour(s) ago
Zepbound’s clinical tests in obstructive sleep apnea showed improvement in breathing disruptions that were accompanied by reductions in body weight. The new approval gives the Eli Lilly medicine the opportunity to become a blockbuster seller in yet another indication.
Source: medcitynews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0
Dexcom recently became the first medical device company to embed generative AI into a continuous glucose monitor. Adding generative AI to the company’s Stelo glucose monitor will give users more personalized recommendations about how to improve their metabolic health, said Dexcom COO Jake Leach.
Source: medcitynews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 02025 and Beyond: Key Trends to Watch in Pharmacy - MedCity News - 17 hour(s) ago
As we all work to wrap up the year and enter into 2025, here are a few trends to keep your eye on in the coming months and beyond.
Source: medcitynews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 1Health for the Holidays: 3 Strategies for Empowering Medication Adherence - MedCity News - 17 hour(s) ago
The best “gift” for a person with chronic conditions is the emotional support and education needed to stay adherent to medications during the hectic holiday season.
Source: medcitynews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 1Safety Signal in Phase 2 Deals a Setback to BioAge Labs’ Muscle-Preserving Obesity Drug - MedCity News - 2 day(s) ago
BioAge Labs said the potential safety problem was observed in some who received experimental drug azelaprag, which is being tested as a monotherapy and in combination with Eli Lilly obesity medication Zepbound. No safety signals were observed in those who received Zepbound alone.
Source: medcitynews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0
Vitalic provides mental health support to older adults. It connects them to a care team that includes geriatric boarded psychiatrists, psychiatric nurse practitioners, licensed therapists and mental health support coaches.
Source: medcitynews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 03D Medical Animation Services: A Revolution in Healthcare Education and Marketing - MedCity News - 3 day(s) ago
3D medical animation services have emerged as a groundbreaking tool in the healthcare industry, revolutionizing the way medical concepts are taught, understood, and marketed.
Source: medcitynews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 1
Four key predictions for the future of clinical trials, examining how these changes will revolutionize the speed, efficiency, and reliability of bringing life-saving treatments to market.
Source: medcitynews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Suki Adds New Features to Help Its AI Assistant Stand Out from Other Tools - MedCity News - 3 day(s) ago
In collaboration with Google Cloud, Suki added two capabilities to its AI assistant: patient summaries and Q&A functionality. These new features might help Suki differentiate itself from other companies selling AI-powered tools to help with documentation and coding, such as Abridge, DeepScribe and Microsoft.
Source: medcitynews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0MedCity Pivot Podcast: Putting a Human Touch on Healthcare Navigation and Coordination - MedCity News - 3 day(s) ago
Heather Cox, President of Insights & Empowerment at Zelis, talked about the company’s care coordination tools with MedCity News Reporter Katie Adams.
Source: medcitynews.comCategories: General Medicine News, General HCPsTweet
Eli Lilly’s Zepbound Becomes First FDA-Approved Drug Therapy for Sleep Apnea https://t.co/OrrIToLAMo